The primacy of public health considerations in defining poor quality medicines

MLA

Newton, Paul N., et al. “The Primacy of Public Health Considerations in Defining Poor Quality Medicines.” PLoS Medicine, vol. 8, no. 12, Dec. 2011. EBSCOhost, https://doi.org/10.1371/journal.pmed.1001139.

APA

Newton, P. N., Amin, A. A., Bird, C., Passmore, P., Dukes, G., Tomson, G., Simons, B., Bate, R., Guerin, P. J., & White, N. J. (2011). The primacy of public health considerations in defining poor quality medicines. PLoS Medicine, 8(12). https://doi.org/10.1371/journal.pmed.1001139

Chicago

Newton, Paul N., Abdinasir A. Amin, Chris Bird, Phillip Passmore, Graham Dukes, Goran Tomson, Bright Simons, Roger Bate, Philippe J. Guerin, and Nicholas J. White. 2011. “The Primacy of Public Health Considerations in Defining Poor Quality Medicines.” PLoS Medicine 8 (12). doi:10.1371/journal.pmed.1001139.